Contract HHSN261201600681P
Eurofins Genomics Blue Heron Llc · Department Of Health And Human Services · September 8, 2016
Eurofins Genomics Blue Heron Llc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 8, 2016 for $11,000 of work in biological product (except diagnostic) manufacturing. Performance is in Bothell, WA. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 18, 2021.
Contract details
- PIID
- HHSN261201600681P
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Bothell, WA
- First action
- September 8, 2016
- Latest action
- March 18, 2021
Description
BLUE HERON BIOTECHNOLOGY INC:1108507 [16-060749]
Modification timeline
-
March 18, 2021Mod P00002$-217
-
February 23, 2021Mod P00001$-4.0K
-
September 8, 2016Base award$14.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN261201600681P?
Contract HHSN261201600681P is a federal contract awarded to Eurofins Genomics Blue Heron Llc by Department Of Health And Human Services on September 8, 2016 for $11,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 2 times since the base award.
Who won contract HHSN261201600681P?
Eurofins Genomics Blue Heron Llc won contract HHSN261201600681P from Department Of Health And Human Services.
How much is contract HHSN261201600681P worth?
Contract HHSN261201600681P has obligated $11,000 to date.